Marimed (MRMD) Assets (2011 - 2026)

Marimed (MRMD) has reported Assets for 16 consecutive years, with $197.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets fell 3.49% year-over-year to $197.2 million in Q2 2026; TTM through Jun 2026 was $197.2 million, a 3.49% decrease from a year earlier, with the FY2025 full-year figure at $202.6 million, down 2.14% from the prior year.
• Assets was $197.2 million for Q2 2026 at Marimed, down from $201.2 million in the prior quarter.
• Over five years, Assets peaked at $212.7 million in Q3 2024 and troughed at $135.9 million in Q2 2022.
• A 5-year average of $187.7 million and a median of $199.2 million in 2026 frame the typical range for Assets.
• Across the five-year window, Assets soared 52.23% in 2022 and retreated 3.49% in 2026, its largest moves.
• Over 5 years, Assets stood at $152.2 million in 2022, then grew by 28.86% to $196.1 million in 2023, then rose by 5.54% to $207.0 million in 2024, then dropped by 2.14% to $202.6 million in 2025, then declined by 2.63% to $197.2 million in 2026.
• The last three Assets figures came in at $197.2 million (Q2 2026), $201.2 million (Q1 2026), and $202.6 million (Q4 2025), per Business Quant data.